| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 42.48T | 42.91T | 45.18T | 32.69T | 21.69T | 21.58T |
| Gross Profit | 24.89T | 22.43T | 21.05T | 20.45T | 14.92T | 8.19T |
| EBITDA | 11.41T | 9.77T | 9.23T | 10.69T | 6.84T | 1.05T |
| Net Income | 7.34T | 6.27T | 6.12T | 6.78T | 4.09T | 275.99B |
Balance Sheet | ||||||
| Total Assets | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
| Cash, Cash Equivalents and Short-Term Investments | 33.34T | 30.06T | 36.13T | 28.77T | 24.54T | 23.38T |
| Total Debt | 27.87T | 29.91T | 32.56T | 41.17T | 31.46T | 34.36T |
| Total Liabilities | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
| Stockholders Equity | 42.38T | 43.54T | 38.09T | 39.09T | 32.23T | 26.55T |
Cash Flow | ||||||
| Free Cash Flow | 136.12B | -19.94T | 16.74T | 3.03T | 3.91T | 9.70T |
| Operating Cash Flow | 2.33T | -17.89T | 19.15T | 6.56T | 6.10T | 11.23T |
| Investing Cash Flow | -2.28T | -559.20B | -159.69B | -4.65T | -650.49B | -7.52T |
| Financing Cash Flow | 5.09T | 9.09T | 11.59T | 853.44B | -6.81T | -4.92T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $9.60B | 13.11 | 9.32% | 2.38% | 33.87% | 12.26% | |
73 Outperform | $23.26B | 13.12 | 18.12% | 4.82% | 8.72% | 27.70% | |
71 Outperform | $16.98B | 17.02 | 17.06% | 10.29% | -6.79% | 16.13% | |
71 Outperform | $20.06B | 15.51 | 21.29% | 5.56% | -11.64% | -8.75% | |
69 Neutral | $15.33B | 13.50 | 24.13% | 4.29% | 12.43% | 56.30% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | $23.68B | 22.45 | 9.34% | 4.98% | 1.13% | -11.93% |